Weill Cornell adds graduate programs at Houston Methodist
February 26, 2021
In an expansion of its biomedical education curricula, Weill Cornell Medicine is launching an additional site for graduate programs at Houston Methodist for the 2021-22 academic year.
This new site, offered by the Weill Cornell Graduate School of Medical Sciences at Houston Methodist, builds on the 16-year academic affiliation between the two academic medical institutions.
The Weill Cornell Graduate School of Medical Sciences, based in New York City, will offer doctorates at Houston Methodist in two areas of study: physiology, biophysics and structural biology (PBSB); and in neuroscience. Applications to the PBSB program will be accepted in February 2021 for the fall semester.
January 26, 2021
Researchers at Weill Cornell Medicine and Cornell’s Ithaca campus have developed a new computational method for studying genetic and environmental interactions and how they influence disease risk.
The research, published Jan. 7 in The American Journal of Human Genetics, makes the process of finding these interactions much less difficult and demonstrates their importance in determining body mass index and diabetes risk.
“Our study demonstrates that your genes matter and the environment matters and that the interaction of the two can increase risk for disease,” said co-senior author Olivier Elemento, a professor of computational genomics in computational biomedicine, professor of physiology and biophysics, associate director of the HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsaud Institute for Computational Biomedicine, and director of the Caryl and Israel Englander Institute for Precision Medicine at Weill Cornell Medicine.
Researchers develop new computational method for studying genetic and environmental interactions
Researchers at Weill Cornell Medicine and Cornell University s Ithaca campus have developed a new computational method for studying genetic and environmental interactions and how they influence disease risk.
The research, published Jan. 7 in
The American Journal of Human Genetics, makes the process of finding these interactions much less difficult and demonstrates their importance in determining body mass index and diabetes risk. Our study demonstrates that your genes matter and the environment matters and that the interaction of the two can increase risk for disease, said co-senior author, Dr. Olivier Elemento, who is professor of computational genomics in computational biomedicine, professor of physiology and biophysics, associate director of the HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsaud Institute for Computational Biomedicine, and director of the Caryl and Israel Englan
E-Mail
Researchers at Weill Cornell Medicine and Cornell University s Ithaca campus have developed a new computational method for studying genetic and environmental interactions and how they influence disease risk.
The research, published Jan. 7 in
The American Journal of Human Genetics, makes the process of finding these interactions much less difficult and demonstrates their importance in determining body mass index and diabetes risk. Our study demonstrates that your genes matter and the environment matters and that the interaction of the two can increase risk for disease, said co-senior author, Dr. Olivier Elemento, who is professor of computational genomics in computational biomedicine, professor of physiology and biophysics, associate director of the HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsaud Institute for Computational Biomedicine, and director of the Caryl and Israel Englander Institute for Precision Medicine at Weill Cornell Medicine.
Studies offer tips on lessening spaceflight-related risk
December 4, 2020
Space travel, illnesses like COVID-19 and climbing Mount Everest can trigger the body’s stress response systems in similar ways, according to new studies by Weill Cornell Medicine, space agencies and other investigators.
The discoveries, including new maps of the abundance of mutations and immune changes found in blood cells during spaceflight, may lead to new ways to protect space travelers. They may also provide insights on caring for Earth-bound patients with illnesses that trigger similar physiological responses.
Christopher Mason, an associate professor of physiology and biophysics at Weill Cornell Medicine, led multiple studies by teams of investigators spanning four of the largest space agencies in the world – NASA; the Japan Aerospace Exploration Agency (JAXA); the European Space Agency (ESA); and Russia’s ROSCOSMOS – as well as academic institutions and industry groups.